Gastroenterology
Volume 126, Issue 2 , Pages 460-468 , February 2004

Diabetes increases the risk of chronic liver disease and hepatocellular carcinoma

  • Hashem B. El-serag

      Affiliations

    • Corresponding Author InformationHashem B. El-Serag, M.D., M.P.H., The Houston Veterans Affairs Medical Center (152), 2002 Holcombe Boulevard, Houston, Texas 77030, USA; fax: (713) 748-7359
    • The Sections of Gastroenterology and Health Services Research at the Houston Department of Veterans Affairs Medical Center and Baylor College of Medicine, Houston, Texas, USA
    • Dr. El-Serag is a VA HSR&D Awardee (RCD00-013-2).
    • ,
  • Thomas Tran

      Affiliations

    • Department of Medicine, Baylor College of Medicine, Houston, Texas, USA
    • ,
  • James E. Everhart

      Affiliations

    • National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), Bethesda, Maryland, USA

Received 2 June 2003 ,Accepted 13 October 2003.

References 

  1. Kim WR, Brown RS, Terrault NA, El-Serag H. Burden of liver disease in the United States (summary of a workshop). Hepatology. 2002;36:227–242
  2. El-Serag HB, Mason AC. Rising incidence of hepatocellular carcinoma in the United States. N Engl J Med. 1999;340:745–750
  3. El-Serag HB, Mason AC. Risk factors for the rising rates of primary liver cancer in the United States. Arch Intern Med. 2000;160:3227–3230
  4. Ruhl CE, Everhart JE. Determinants of the association of overweight with elevated serum alanine aminotransferase activity in the United States. Gastroenterology. 2003;124:71–79
  5. Greeve M, Ferrell L, Kim M, Combs C, Robert J, Ascher N, et al. Cirrhosis of undefined pathogenesis (absence of evidence for unknown or autoimmune processes). Hepatology. 1993;17:593–598
  6. Lee R. Nonalcoholic steatohepatitis (a study of 49 patients). Hum Pathol. 1989;20:594–598
  7. Powell E, Cooksley W, Hanson R, Searle J, Halliday J, Powell L. The natural history of nonalcoholic steatohepatitis (a follow-up study of forty-two patients for up to 21 years). Hepatology. 1990;11:74–80
  8. Angulo P, Keach J, Batts K, Lindor K. Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis. Hepatology. 1999;30:1356–1362
  9. Di Bisceglie AM, Carithers RL, Gores GL. Hepatocellular carcinoma. Hepatology. 1998;28:1161–1165
  10. El-Serag HB, Richardson PA, Everhart JE. The role of diabetes in hepatocellular carcinoma (a case-control study among United States veterans). Am J Gastroenterol. 2001;96:2462–2467
  11. Matteoni C, Younossi Z, Gramlich T, Bopari N, Liu Y, McCullough A. Nonalcoholic fatty liver disease (a spectrum of clinical and pathological severity). Gastroenterology. 1999;116:1413–1419
  12. Marchesini G, Brizi M, Morselli-Labate A, Bianchi G, Bugianesi E, McCullough A, et al. Association of nonalcoholic fatty liver disease with insulin resistance. Am J Med. 1999;107:450–455
  13. Belfiore F, Iannello S. Insulin resistance in obesity (metabolic mechanisms and measurement methods). Mol Genet Metab. 1998;65:121–128
  14. Falck-Ytter , Younossi Z, Marchesini G, McCullough A. Clinical features and natural history of nonalcoholic steatosis syndromes. Semin Liver Dis. 2001;21:17–26
  15. Cotrim H, Parana R, Braga E, Lyra L. Nonalcoholic steatohepatitis and hepatocellular carcinoma (natural history?). Am J Gastroenterol. 2000;95:3018–3019
  16. Zen Y, Katayanagi K, Tsuneyama K, Harada K, Araki I, Nakanuma Y. Hepatocellular carcinoma arising in non-alcoholic steatopathtis. Pathol Int. 2001;51:127–131
  17. Shimada M, Hashimoto E, Taniai M, Hasegawa K, Okuda H, Yayashi N, et al. Hepatocellular carcinoma in patients with non-alcoholic steatohepatitis. J Hepatol. 2002;37:154–160
  18. Kessler II. Cancer mortality among diabetics. J Natl Cancer Inst. 1970;44:2051–2055
  19. Ragozzino M, Melton LJ, Chu CP, Palumbo PJ. Subsequent cancer risk in the incidence cohort of Rochester, Minnesota, residents with diabetes mellitus. J Chronic Dis. 1982;35:13–19
  20. Lu SN, Lin TM, Chen CJ, Chen JS, Liaw YF, Chang WY, et al. A case-control study of primary hepatocellular carcinoma in Taiwan. Cancer. 1988;62:2051–2055
  21. Kingston ME, Ali MA, Atiyeh M, Donnelly RJ. Diabetes mellitus in chronic active hepatitis and cirrhosis. Gastroenterology. 1984;87:688–694
  22. Lawson DH, Gray JM, McKillop C, Clarke J, Lee FD, Patrick RS. Diabetes mellitus and primary hepatocellular carcinoma. Q J Med. 1986;61:945–955
  23. La Vecchia C, Negri E, D’Avanzo B, Boyle P, Franceschi SD. Medical history and primary liver cancer. Cancer Res. 1990;50:6274–6277
  24. Yu MC, Tong MJ, Govindarajan S, Henderson BE. Non-viral risk factors for hepatocellular carcinoma in a low-risk population, the non-Asians of Los Angeles County, California. J Natl Cancer Inst. 1991;83:1820–1826
  25. Adami HO, McLaughlin J, Ekbom A, Berne C, Silverman D, Hacker D, et al. Cancer risk in patients with diabetes mellitus. Cancer Causes Control. 1991;2:307–314
  26. La Vecchia C, Negri E, Franceschi SD, D’Avanzo B, Boyle P. A case-control study of diabetes mellitus and cancer risk. Br J Cancer. 1994;70:950–953
  27. Adami HO, Chow WH, Nyren O, Berne C, Linet MS, Ekbom A, et al. Excess risk of primary liver cancer in patients with diabetes mellitus. J Natl Cancer Inst. 1996;88:1472–1477
  28. La Vecchia C, Negri E, DeCarli A, Franceschi SD. Diabetes mellitus and the risk of primary liver cancer. Int J Cancer. 1997;73:204–207
  29. Braga C, La Vecchia C, Negri E, Franceschi S. Attributable risks for hepatocellular carcinoma in Northern Italy. Eur J Cancer. 1997;33:629–634
  30. Wideroff L, Gridley G, Mellemkjaer L, Chow WH, Linet M, Keehn S, et al. Cancer incidence in a population-based cohort of patients hospitalized with diabetes mellitus in Denmark. J Natl Cancer Inst. 1997;89:1360–1365
  31. Lagiou P, Kuper H, Stuver S, Tzonou A, Trichopoulos D, Adami HO. Role of diabetes mellitus in the etiology of hepatocellular carcinoma. J Natl Cancer Inst. 2000;92:1096–1099
  32. Fujino Y, Mizoue T, Tokui N, Yoshimura T. Prospective study of diabetes mellitus and liver cancer in Japan. Diabetes Metab Res Rev. 2001;17:374–379
  33. Tazawa J, Maeda M, Nakagawa M, Ohbayashi H, Kusano F, Yamane M, et al. Diabetes mellitus may be associated with hepatocarcinogenesis in patients with chronic hepatitis C. Dig Dis Sci. 2002;47:710–715
  34. Hassan M, Hwang L, Hatten C, Swaim M, Li D, Abbruzzese J, et al. Risk factors for hepatocellular carcinoma (synergism of alcohol with viral hepatitis and diabetes mellitus). Hepatology. 2002;36:1206–1213
  35. Department of Health and Human Services . In: 3rd ed.. The international classification of diseases, 9th rev., clinical modification: ICD-9-CM.Diseases: tabular list. Volume 1:Washington, DC: Government Printing Office; 1989; March. (DHHS publication no. (PHS) 89–1260.)
  36. Boyko EJ, Koepsell TD, Gaziano JM, Horner RD, Feussner JR. US Department of Veterans Affairs medical care system as a resource to epidemiologists. Am J Epidemiol. 2000;151:307–314
  37. Page WF. VA mortality reporting for World War II army veterans. Am J Epidemiol. 1992;82:124–125
  38. Page WF, Mahan CM, Kang HK. Vital status ascertainment through the files of the department of Veterans Affairs and the social security administration. Ann Epidemiol. 1996;6:102–109
  39. Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use of the ICD-9-CM in administrative databases. J Clin Epidemiol. 1992;45:613–619
  40. Harris MI, Klein R, Welborn TA, Knuiman MW. Onset of NIDDM occurs at least 4–7 years before clinical diagnosis. Diabetes Care. 1992;15:815–819
  41. Poonawala A, Nair S, Thuluvath P. Prevalence of obesity and diabetes in patients with cryptogenic cirrhosis (a case-control study). Hepatology. 2000;32:689–692
  42. Amarapurkar D, Das H. Chronic liver disease in diabetes mellitus. Trop Gastroenterol. 2002;23:3–5
  43. Megyesi C, Samols E, Matks V. Glucose tolerance and diabetes in chronic liver disease. Lancet. 1967;2:1051–1056
  44. Conn H, Schreiber W, Elkington SG, Johnson TR. Cirrhosis and diabetes (Increased incidence of diabetes in patients with Laennec’s cirrhosis). Am J Dig Dis. 1969;14:837–852
  45. Muting D, Wohlgemuth D, Dorsett R. Liver cirrhosis and diabetes mellitus. Geriatrics. 1969;24:91–99
  46. Shmueli E, Record C, Alberti K. Liver disease, carbohydrate metabolism and diabetes. Bailleres Clin Endocrinol Metab. 1992;6:719–743
  47. Kashner TM. Agreement between administrative files and written medical records (a case of the Department of Veterans Affairs). Med Care. 1998;36:1324–1336
  48. Pessayre D, Berson A, Fromenty B, Mansouri A. Mitochondria in steatohepatitis. Sem Liver Dis. 2001;21:57–69
  49. Chitturi S, Farrell G. Etiopathogenesis of nonalcoholic steatohepatitis. Sem Liver Dis. 2001;21:27–41
  50. Fong D, Nehra V, Lindor K, Buchman AL. Metabolic and nutritional considerations in nonalcoholic fatty liver. Hepatology. 2000;32:3–10
  51. National Center for Health Statistics . Health, United States. Washington DC: Government Printing Office; 1998;

PII: S0016-5085(03)01733-5

doi: 10.1053/j.gastro.2003.10.065

Gastroenterology
Volume 126, Issue 2 , Pages 460-468 , February 2004

Article Tools

* Image Usage & Resolution